Skip to main content
All Protocols
Protocol · 16 weeks

Muscle Preservation 50+

Sarcopenia defense + strength longevity

Why this is good for you

Strength and lean mass after 50 are the strongest modifiable predictors of independent living and survival.

  • Higher lean mass and grip strength predict lower all-cause mortality
  • Resistance training improves bone density — fewer life-shortening fractures
  • Better insulin sensitivity and glucose disposal via muscle

Overview

A 16-week sarcopenia defence stack: hypertrophy-led training, leucine-anchored protein dosing, creatine, and optional growth-axis peptide support.

Who this is for

  • ·Adults 50+ losing strength or grip year on year
  • ·Post-menopausal women defending bone + muscle
  • ·Returning to lifting after a layoff

The four pillars

Progressive overload

3–4 strength sessions/week, compound lifts, 6–12 reps to RIR 1–2.

Protein dosing

1.6–2.2 g/kg/day, 3–4 doses of 30–45 g with 3 g leucine each.

Creatine

5 g/day, indefinitely. Single best-evidenced ergogenic + cognitive aid.

Recovery

8 h sleep window, omega-3, magnesium.

Phased timeline

Phase 1 · Weeks 1–4

Build pattern

Movement quality + protein habit

  • 3× full-body sessions
  • Hit protein target daily
Phase 2 · Weeks 5–12

Load

Progressive overload

  • 4× sessions
  • Track top sets
  • Add creatine + omega-3
Phase 3 · Weeks 13–16

Peak + reassess

DEXA + strength retest

  • DEXA scan
  • 1RM retest
  • Consider CJC-1295/Ipamorelin under physician

Daily schedule

07:00Protein 40 g + creatine 5 g
12:00Protein 40 g lunch
17:00Strength training 4×/week
19:00Protein 40 g dinner + omega-3 2 g
21:30Magnesium glycinate, vitamin D3/K2

Biomarkers to track

MarkerTargetRationale
Grip strength+10%Strong mortality predictor.
DEXA lean mass+1–2 kgSarcopenia reversal.
IGF-1Age-normal upper thirdAnabolic environment.

Cautions & contraindications

  • · Active malignancy (GH-axis caution)
  • · Uncontrolled hypertension

Educational content only — consult a qualified physician before starting any protocol.

Selected references